JBCHEPHARM — J B Chemicals and Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Market Cap
IN₹249.15bn
Enterprise Value
IN₹245.85bn
Revenue
IN₹34.84bn

Annual income statement for J B Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,747	20,425	24,242	31,493	34,842
Cost of Revenue
Gross Profit	10,589	12,625	14,894	18,729	21,932
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,667	15,550	19,496	25,569	27,298
Operating Profit	3,080	4,875	4,746	5,924	7,544
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,489	5,969	5,049	5,552	7,515
Provision for Income Taxes
Net Income After Taxes	2,707	4,485	3,860	4,100	5,526
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	2,720	4,480	3,854	4,098	5,526
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,720	4,480	3,854	4,098	5,526
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17.4	26.4	24.8	26.2	34.9
Dividends per Share